Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify

BACKGROUND AND AIMS: The aMAP score is a model that predicts risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis. Its performance in a ‘real world’ surveillance setting has not yet been ascertained. PATIENTS AND METHODS: We had access to a cohort of 3473 individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Philip J., Innes, Hamish, Hughes, David M., Kalyuzhnyy, Anton, Kumada, Takashi, Toyoda, Hidenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519948/
https://www.ncbi.nlm.nih.gov/pubmed/35798825
http://dx.doi.org/10.1038/s41416-022-01851-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519948/
https://www.ncbi.nlm.nih.gov/pubmed/35798825
http://dx.doi.org/10.1038/s41416-022-01851-1

Ejemplares similares